FDA Approves CLINDAMYCIN PHOSPHATE — Encube Ethicals, Inc.
# FDA Approves Encube Ethicals' Generic Clindamycin Phosphate Gel Encube Ethicals, Inc. received FDA approval for its generic clindamycin phosphate gel 1% (ANDA212438), a topical …
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves Encube Ethicals' Generic Clindamycin Phosphate Gel Encube Ethicals, Inc. received FDA approval for its generic clindamycin phosphate gel 1% (ANDA212438), a topical …
# FDA Approves Generic Everolimus from Natco Pharma Natco Pharma Limited received FDA approval for its generic version of everolimus, an oral immunosuppressant and cancer therapeu…
Alvogen Inc. secured FDA approval for ANDA 208269 to market generic Hydrocodone Bitartrate oral tablets, positioning the company to influence market pricing within the opioid segme…
# FDA Approval Newswire **Sentynl Therapeutics Receives FDA Approval for NULIBRY (Fosdenopterin Hydrobromide), Expanding Treatment Options in Rare Disease Market** The FDA approv…
# FDA Approves Dr. Reddy's Laboratories Vigabatrin Generic, Expanding Market Competition Dr. Reddy's Laboratories Inc. has received FDA approval for its generic vigabatrin oral fo…
Sigmapharm Laboratories secured FDA approval for its generic, sublingual Asenapine tablets, a development expected to increase generic market penetration and exert competitive pric…
Dr. Reddy's Laboratories Limited received FDA approval for its generic capecitabine, an oral chemotherapy agent, strengthening its position in the U.S. oncology market and expandin…
# FDA Approves Ingenus Pharmaceuticals' Generic Scopolamine Transdermal Patch Ingenus Pharmaceuticals, LLC has received FDA approval for its generic scopolamine transdermal patch …
# FDA Approves Generic Drug Application for Accord Healthcare Accord Healthcare received FDA approval for ANDA 214425 on November 13, 2020, expanding its generic pharmaceutical po…
# FDA Approves Generic Pomalidomide; Aurobindo Pharma Enters Multiple Myeloma Market Aurobindo Pharma Limited received FDA approval for its generic pomalidomide oral formulation, …
Leading Pharma, LLC received FDA approval for generic oral Leucovorin Calcium, introducing a new entrant that is expected to intensify competition and exert downward pressure on pr…
# FDA Approves Harmony Biosciences' WAKIX for Narcolepsy Treatment Harmony Biosciences announced FDA approval of WAKIX (pitolisant hydrochloride), an oral histamine H3-receptor an…
# FDA Approves Lifestar Pharma's Generic Acetazolamide The U.S. Food and Drug Administration has approved Lifestar Pharma LLC's abbreviated new drug application for generic acetaz…
SpecGx LLC has secured FDA approval for the generic oral formulation of Diphenoxylate Hydrochloride and Atropine Sulfate, positioning the company to enter the market and increase c…
Pfizer’s FDA approval of XELJANZ reinforces its competitive position in the rheumatology market, expected to drive incremental sales growth as it captures share from existing biolo…
# FDA Approves Celgene's ONUREG (Azacitidine) as First Oral Maintenance Therapy for AML The FDA approval of Celgene Corporation's ONUREG (azacitidine) marks a significant market o…
Accord Healthcare announced FDA approval for a new drug application on Aug. 24, 2020, which market analysts expect to broaden the company’s product portfolio and drive incremental …
# FDA Approves Generic Gabapentin from Zhejiang Yongtai Pharmaceutical The U.S. Food and Drug Administration has approved Zhejiang Yongtai Pharmaceutical Co., Ltd.'s generic formu…
# FDA Approves Genentech's ENSPRYNG for Neuromyelitis Optica Spectrum Disorder The FDA has approved Genentech's ENSPRYNG (satralizumab), a subcutaneous monoclonal antibody therapy…
# FDA Approves Genentech's EVRYSDI (risdiplam) for Spinal Muscular Atrophy Genentech announced FDA approval of EVRYSDI (risdiplam), an oral treatment for spinal muscular atrophy, …